Community-Acquired Pneumonia in Children Caused by Pneumococci of MLSB- and M-Phenotype: Clinical Cases
The key to effective treatment of a bacterial infection is a rapid and proper selection of antimicrobial therapy. WHO and UNICEF developed the Global Action Plan for the Prevention and Control of Pneumonia and Diarrhoea (GAPPD) aimed to elimination of the preventable causes of child death by 2025 by...
Saved in:
Main Authors: | Natalya A. Ilenkova, Irina N. Protasova, Elena S. Sokolovskaya |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2017-06-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/1750 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Community-acquired pneumonia briefly about the main. What is important to know to the physician. Based on the materials of the Russian National Congress «Man and Drug» and the III Pulmonology Summit
by: Yu. V. Evsutina
Published: (2021-06-01) -
SEROTYPES AND ANTIMICROBIAL SUSCEPTIBILITY OF NASOPHARYNGEAL PNEUMOCOCCI ISOLATED FROM CHILDREN IN 2010–2016: A RETROSPECTIVE COHORT STUDY
by: Nikolay A. Mayanskiy, et al.
Published: (2017-11-01) -
Effectiveness of antimicrobial therapy for community-acquired pneumonia in real clinical practice
by: O. M. Uryasev, et al.
Published: (2022-01-01) -
Novelties in the treatment of community-acquired and hospital-acquired pneumonia
by: Matteo Bassetti, et al.
Published: (2025-04-01) -
Antibiotic Therapy of Severe Community-Acquired Pneumonia
by: O. V. Molchanova, et al.
Published: (2020-05-01)